RMS Updates: Fringe Methodology and Workday Refactoring

Published July 7, 2021 As previously announced, the fringe calculation methodology required by Workday and updated F&A Rates are scheduled to be released in RMS on July 19, 2021. The new fringe calculation is a flat rate based on job/appointment type and funding source (federal/state/local or other). An updated Fringe Calculation Spreadsheet tool will be […]

NSF Announces Revised Current and Pending Support FAQs

Published July 1, 2021 The National Science Foundation issued the following update: The NSF has issued revised Frequently Asked Questions (FAQs) Regarding Current and Pending Support. These FAQs have been revised for consistency with the newly developed table entitled NSF Pre-award and Post-award Disclosures Relating to the Biographical Sketch and Current and Pending Support. Questions for the NSF can […]

NSF Announces Revised Proposal and Award Policies and Procedures Guide

Published June 28, 2021 The National Science Foundation issued the following update: A revised version of the NSF Proposal & Award Policies & Procedures Guide (PAPPG) (NSF 22-1) has been issued. The new PAPPG will be effective for proposals submitted or due on or after October 4, 2021. Significant changes include: A new section covering requests for reasonable […]

Workday Updates: SPA Forms and Naming Conventions

Published June 23, 2021 Naming ConventionFor new awards set up in Workday, research administrators will no longer be able to reference the department and fund numbers found in AIS. Instead, there will be a new naming convention that incorporates the PI’s (Assignee’s) name, the title of the project and a department-assigned nickname (if provided). These values […]

NSF Pre-award and Post-award Disclosures Relating to the Biographical Sketch and Current and Pending Support

Published June 21, 2021 On June 16, 2021, the NSF announced the following information. In an effort to provide the community with helpful reference information regarding pre-award and post-award disclosure information in the biographical sketch and current and pending support proposal sections, the NSF has developed a disclosure table entitled, NSF Pre-award and Post-award Disclosures Relating to […]

RMS Updates: Fringe Methodology and Workday Refactoring

Published June 18, 2021 Washington University in St. Louis has reached agreement with our Federal cognizant agency, the Department of Health and Human Services, on predetermined Fringe Benefit and Facilities and Administrative (F&A) cost rates. This new rate agreement is effective July 1, 2021, and it covers fiscal years 2022 through 2025. To allow Workday stabilization and […]

Research Monitor’s Access in MyDay

Published June 17, 2021 All Research Monitors must complete “HIPAA Training for Research Monitors.” The Research Monitor will request a Guest WUSTL Key. The Department will approve the Guest WUSTL Key. The Research Monitor will receive the WUSTL Key information via email from WashU Information Technology. The Guest WUSTL Key may take 1-3 days to […]

Working Alone in Research Laboratories

Published June 11, 2021 How and when we conduct research has changed dramatically over the past 15 months. Working alone is not unique to alternate operations due to COVID-19; however, situations where researchers needed to work alone increased during this time. While conducting research activities alone in the laboratory may be necessary and is part […]

Chemical and Unwanted Material Management Reminders

Published June 7, 2021 As research continues to ramp up to pre-COVID levels, Environmental Health and Safety (EH&S) has observed an increase in issues associated with chemical and unwanted material management. The following reminders are based on learnings from these issues: Biological waste containers should not be used for chemical disposal, radioactive material disposal or […]

FDA’s Enforcement of ClinicalTrials.gov Reporting

Published June 1, 2021 Clinical trial sponsors, including sponsor-investigators who are academic researchers, have been required by law to register and report results on applicable clinical trials¹ in the ClinicalTrials.gov database for more than a decade. Events that occurred over the last year, and those occurring more recently, indicate the FDA’s intention to exercise its enforcement authority. […]